Market Intel: Orthobiologics Market Well-Positioned For Innovative Reconstruction
• By Gayle Grimes
Global sales of orthobiologics for musculoskeletal soft tissue replacement and regeneration are predicted to hit $1.4bn by 2021, driven largely by rising numbers of sports injuries requiring treatment, but also by a higher prevalence of osteoarthritis and a need for innovative treatments for musculoskeletal repair. This article offers an in-depth look at the orthobiologics market landscape for cartilage, meniscus and ligament/tendon replacement and regeneration, as well as insight from an orthopedic surgeon. It also analyzes key players in these markets and highlights emerging trends and the greatest barriers for wider adoption of products.
The global market for orthobiologic products used in musculoskeletal soft tissue replacement and regeneration is expected to expand at a compound annual growth rate of 5.9% to reach $1.4bn by 2021.
